首页> 外文期刊>Artificial cells, nanomedicine, and biotechnology. >Beta carotene-loaded zein nanoparticles to improve the biopharmaceutical attributes and to abolish the toxicity of methotrexate: a preclinical study for breast cancer
【24h】

Beta carotene-loaded zein nanoparticles to improve the biopharmaceutical attributes and to abolish the toxicity of methotrexate: a preclinical study for breast cancer

机译:加载β-胡萝卜素的玉米醇溶蛋白纳米颗粒可改善生物药物特性并消除甲氨蝶呤的毒性:乳腺癌的临床前研究

获取原文
           

摘要

Beta carotene (βC) loaded nanoparticles of zein (βC-NPs) were developed using modified phase separation technique. βC-NPs were prepared using different zein concentration and optimized formulation was selected on the basis of micromeritics properties and entrapment efficiency. Further, βC-NPs were evaluated for in vitro release, in vitro cell-survival, cellular localization and apoptosis induced in MCF-7 cells. The combined effect of the βC and its nanoparticulate counterpart with MTX was evaluated thereafter for cytotoxicity and apoptotic activity in MCF-7 cells. In comparison to free βC, the βC-NPs demonstrated noteworthy improvement in various biopharmaceutical attributes viz Cmax (~2.3-folds), AUCtotal (2.7-folds), t1/2 (~1.5 folds) and MRT (~1.5 folds), further indicating the remarkable increment in oral bioavailability of βC after incorporation in zein nanoparticles. The anti-tumour potential of prepared βC-NPs and effects of free βC and βC-NPs were investigated upon anticancer efficacy of methotrexate (MTX) in experimentally induced breast cancer rat model. Protective role of βC on MTX-associated hepatic toxicity in wistar rats was also determined using haematological and histopathological approaches. In a nutshell, zein nanoparticles improved the cellular uptake, cytotoxicity and exhibited enhanced oral biopharmaceutical performance of βC. This combination regimen could also be promising platform to facilitate the therapeutic benefits of anticancer agents.
机译:使用改进的相分离技术开发了玉米醇溶蛋白(βC-NPs)的β-胡萝卜素(βC)负载纳米颗粒。用不同玉米醇溶蛋白浓度制备βC-NPs,并根据微胶束性质和包封率选择最佳配方。此外,评估了βC-NPs在MCF-7细胞中诱导的体外释放,体外细胞存活,细胞定位和凋亡。随后评估βC及其纳米颗粒对应物与MTX的联合作用,以评估MCF-7细胞的细胞毒性和凋亡活性。与游离βC相比,βC-NPs在各种生物药物特性方面均表现出显着改善,即Cmax(〜2.3倍),AUCtotal(2.7倍),t1 / 2(〜1.5倍)和MRT(〜1.5倍)。表明掺入玉米醇溶蛋白纳米颗粒后,βC的口服生物利用度显着增加。研究了甲氨蝶呤(MTX)在实验性诱导的乳腺癌大鼠模型中的抗癌作用,研究了制备的βC-NPs的抗肿瘤潜力以及游离βC和βC-NPs的作用。还使用血液学和组织病理学方法确定了βC对wistar大鼠MTX相关肝毒性的保护作用。简而言之,玉米醇溶蛋白纳米颗粒改善了细胞摄取,细胞毒性并表现出增强的βC口服生物药物性能。该组合方案也可能是促进抗癌药治疗益处的有前途的平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号